advertisement
Fuchshofer R 11
Showing records 1 to 11 | Display all abstracts from Fuchshofer R107691 Enhanced glaucomatous damage accompanied by glial response in a new multifactorial mouse model
Reinehr S
Frontiers in immunology 2022; 13: 1017076
108689 CCN2/CTGF tip the balance of growth factors towards TGF-β2 in primary open-angle glaucoma
Dillinger AE
Frontiers in molecular biosciences 2023; 10: 1045411
107691 Enhanced glaucomatous damage accompanied by glial response in a new multifactorial mouse model
Girbig RM
Frontiers in immunology 2022; 13: 1017076
108689 CCN2/CTGF tip the balance of growth factors towards TGF-β2 in primary open-angle glaucoma
Kuespert S
Frontiers in molecular biosciences 2023; 10: 1045411
107691 Enhanced glaucomatous damage accompanied by glial response in a new multifactorial mouse model
Schulte KK
Frontiers in immunology 2022; 13: 1017076
108689 CCN2/CTGF tip the balance of growth factors towards TGF-β2 in primary open-angle glaucoma
Seleem AA; Neuendorf J
Frontiers in molecular biosciences 2023; 10: 1045411
107691 Enhanced glaucomatous damage accompanied by glial response in a new multifactorial mouse model
Theile J
Frontiers in immunology 2022; 13: 1017076
108689 CCN2/CTGF tip the balance of growth factors towards TGF-β2 in primary open-angle glaucoma
Schneider M
Frontiers in molecular biosciences 2023; 10: 1045411
107691 Enhanced glaucomatous damage accompanied by glial response in a new multifactorial mouse model
Asaad MA
Frontiers in immunology 2022; 13: 1017076
108689 CCN2/CTGF tip the balance of growth factors towards TGF-β2 in primary open-angle glaucoma
Fuchshofer R
Frontiers in molecular biosciences 2023; 10: 1045411
107691 Enhanced glaucomatous damage accompanied by glial response in a new multifactorial mouse model
Fuchshofer R; Dick HB; Joachim SC
Frontiers in immunology 2022; 13: 1017076
